Expression of GLUT-2 antisense RNA in beta cells of transgenic mice leads to diabetes

J Biol Chem. 1994 Nov 18;269(46):28543-6.

Abstract

An insulin response to glucose is required to correct hyperglycemia. Two proteins, the glucose transporter GLUT-2 and the glucose-phosphorylating enzyme glucokinase, have been implicated in the control of glucose metabolism in beta cells. To study the role of glucose transporter GLUT-2 in the regulation of insulin secretion and in the development of diabetes mellitus, we have obtained transgenic mice expressing high levels of GLUT-2 antisense RNA in beta cells. Western blot analysis showed an 80% reduction in GLUT-2 protein in the beta cells of these animals. Islets from transgenic mice showed impaired glucose-stimulated insulin secretion. In addition, much higher levels of blood glucose were detected in transgenic mice than in controls when glucose tolerance tests were performed. These results suggest that the reduction of GLUT-2 in the pancreas could be a crucial step in the development of diabetes mellitus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Diabetes Mellitus, Experimental / genetics*
  • Gene Expression Regulation
  • Glucose Tolerance Test
  • Glucose Transporter Type 2
  • Insulin / genetics
  • Insulin / metabolism
  • Insulin Secretion
  • Islets of Langerhans / metabolism*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Monosaccharide Transport Proteins / genetics*
  • RNA, Antisense / genetics*
  • RNA, Antisense / metabolism

Substances

  • Glucose Transporter Type 2
  • Insulin
  • Monosaccharide Transport Proteins
  • RNA, Antisense